Grants and Contributions

• The CIHR Institute of Health Services and Policy Research (CIHR-IHSPR) has a mandate to support innovative research, capacity-building and knowledge translation initiatives designed to improve the way health care services are organized, regulated, managed, financed, paid for, used and delivered, in the interest of improving the health and quality of life of all Canadians. As part of its 2021-2026 strategic plan, CIHR-IHSPR is committed to supporting advancements in the science of health services and policy research (HSPR) including theoretical, methodological and conceptual innovations that advance research excellence and impact in the field of HSPR.
• Guided by interdisciplinary approaches to HSPR, researchers use a range of novel theories, frameworks, methods and tools to understand, observe and/or measure phenomena related to health service interventions and policies (e.g., methods to integrate an intersectional lens in equity-focused HSPR, advancing embedded research roles and activities, evidence synthesis and support for decision-making, improving theoretical understanding of how policy interventions adapt to varying contexts and population needs, equity-focused priority setting and resource allocation, strengthening methodological approaches to analyzing and reporting data to inform decision-making, advancing Learning Health Systems and rapid research approaches, and more), and to enhance the impact of HSPR on policy and practice.
• The objective of this Priority Announcement is to support research that aims to advance the theories, methods, approaches, conceptual frameworks, and/or tools that underpin the science of HSPR and that advance research excellence and impact in the field. Specifically, this Priority Announcement will support research in one or more of the following domains:
o Domain 1: Develop and/or enhance theoretical and/or conceptual frameworks in HSPR.
o Domain 2: Develop and/or enhance methods and approaches to the conduct of HSPR (e.g., qualitative, quantitative, mixed methods, co-design, rapid response, embedded research, etc.).
o Domain 3: Develop and/or assess valid and reliable measurement tools for use within HSPR
o Domain 4: Develop and/or enhance theories, concepts, frameworks, pathways, and/or indicators for HSPR excellence and impact, where excellence and impact extend beyond academic impact.

• The CIHR Institute of Musculoskeletal Health and Arthritis (CIHR-IMHA) will fund applications that are determined relevant to its mandate and research priority areas as described below:
o IMHA mandate areas related to health systems and services
o Skin
o Oral Health including dental and craniofacial
o Myalgic Encephalomyelitis
o Pain

.
¿ Facilitate effective and meaningful youth and caregiver/family engagement throughout all stages of the project ensuring youth and caregivers/families, as well as providers and policy makers, all play key roles.

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.

• The Institute of Cancer Research (CIHR-ICR) has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation.
• This priority announcement is designed to support CIHR-ICR’s mandate in the following research area:
o Breast Cancer Research

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.

The specific objectives of this funding opportunity are:
• To provide recognition and funding to academic health research trainees;
• To provide a reliable supply of highly skilled and qualified researchers.

• The CIHR HIV/AIDS and STBBI Research Initiative (RI), under the leadership of the CIHR Institute of Infection and Immunity (III), is responsible for funding research on human immunodeficiency virus (HIV), hepatitis B (HBV) and C (HCV), chlamydia, gonorrhea, syphilis, and human papilloma virus (HPV). This funding is provided across all CIHR research themes: biomedical research, clinical research, health services research and social, cultural, environmental and population health research.
• Research that focuses on key populations disproportionately affected by HIV/AIDS and STBBI is highly encouraged.
• This priority announcement will fund two (2) early career investigators for a total of three (3) years.
• In alignment with CIHR's commitment to equity, diversity and inclusion (EDI) in the research system, the RI champions EDI as a means to support excellence in research, training and knowledge mobilization. Therefore, we encourage people from diverse backgrounds, including groups underrepresented in science such as women and racial and ethnic minorities, to apply.
• This priority announcement will prioritize funding for research on HIV and/or STBBI aligned with the CIHR HIV/AIDS Research Initiative: Strategic Plan (2022-2027) in the following research areas:
o Improving health equity by advancing research to understand and address determinants of health, new models of care, or sexual and reproductive health for people living with or at risk of HIV/AIDS and STBBI; or
o Accelerating discovery and innovation by advancing research on innovative technologies for testing and surveillance, interactions among infections and co-morbidities, or design and development of next-generation interventions.
• Should there be no eligible applications relevant to the research areas identified above, applications must be in alignment with the strategic directions of the CIHR HIV/AIDS Research Initiative: Strategic Plan (2022-2027) to be funded.